Epidemiology and Etiology
Use of Menthol Cigarettes, Smoking Frequency, and Nicotine Dependence Among US Youth
Abstract Importance Menthol may make cigarette smoke less aversive and could lead youth to smoke more frequently and become more dependent on nicotine. Objective To assess the association of menthol use with cigarette smoking frequency and...
Four-year health trajectories of children prenatally exposed to cocaine and/or cannabis. A retrospective, cohort study in La Pampa, Argentina
ABSTRACT Cocaine and/or cannabis use during pregnancy is a growing problem of relevance for global public health. Exposed children may have a wide range of perinatal complications, but there is little knowledge on their course. Objective...
Opioid Facts and Figures
Opioid Facts and Figures, recorded 3-June-2022. Presented by Lauran Wirf, DO: Addiction Medicine Fellow; University of Colorado School of Medicine; Denver, Colorado. With the increasing prevalence of illicit fentanyl, it is important for...
Modeling the evolution of the US opioid crisis for national policy development
Abstract The opioid crisis is a major public health challenge in the United States, killing about 70,000 people in 2020 alone. Long delays and feedbacks between policy actions and their effects on drug-use behavior create dynamic complexity...
Use Patterns, Flavors, Brands, and Ingredients of Nonnicotine e-Cigarettes Among Adolescents, Young Adults, and Adults in the United States
Abstract Importance Nonnicotine e-cigarettes contain chemicals, flavorants, and solvents that have known health harms and/or have not been proven safe for inhalation. Objective To evaluate nonnicotine e-cigarette use patterns, including...
Variations in national availability of waivered buprenorphine prescribers by racial and ethnic composition of zip codes
Background Opioid overdose remains a public health crisis in diverse communities. Between 2019 and 2020, there was an almost 40% increase in drug fatalities primarily due to opioid analogues of both stimulants and opioids. Medications for...
New Psychoactive Substances (NPS): Synthetic Stimulants/Synthetic Cannabinoids
ISSUP are pleased to present the First Webinar in a series on New Psychoactive Substances (NPS).
New Psychoactive Substances (NPS): Synthetic Stimulants/Synthetic Cannabinoids
ISSUP would like to invite you to join the First Webinar in a series on New Psychoactive Substances (NPS).
The burden of mental disorders, substance use disorders and self-harm among young people in Europe
Summary Mental health is a public health issue for European young people. The Global Burden of Disease (GBD) Study 2019 provides internationally comparable information on trends in the health status of populations and changes in the leading...
Wastewater analysis and drugs — a European multi-city study 2022
The analysis of municipal wastewaters for drugs and their metabolic products to estimate community consumption is a developing field, involving scientists working in different research areas, including analytical chemistry, physiology...